| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 50 |
| Opened positions | 18 |
| Closed positions | 5 |
| Increased positions | 7 |
| Reduced positions | 13 |
| 13F shares | Current |
|---|---|
| Total value | 113.33 bn |
| Total shares | 62.66 mm |
| Total puts | 37.60 k |
| Total calls | 162.80 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| BVF | 18.83 mm | $75.15 bn |
| dievini Hopp BioTech holding GmbH & Co KG | 16.32 mm | $0.00 |
| Biotechnology Value Fund L P | 7.43 mm | $0.00 |
| AFFiRiS | 6.72 mm | $20.98 mm |
| LLY Eli Lilly and | 3.62 mm | $0.00 |
| BLK BlackRock | 2.61 mm | $10.40 bn |
| Redmile | 1.81 mm | $7.21 bn |
| WFC Wells Fargo & Company | 1.12 mm | $4.48 bn |
| Platinum Investment Management | 952.07 k | $3.80 bn |
| Avidity Partners Management | 825.00 k | $3.29 bn |
